Promoting the use of injectable naltrexone vivitrol in colorado
This presentation is the property of its rightful owner.
Sponsored Links
1 / 6

Promoting the Use of Injectable Naltrexone (Vivitrol) in Colorado PowerPoint PPT Presentation


  • 120 Views
  • Uploaded on
  • Presentation posted in: General

Promoting the Use of Injectable Naltrexone (Vivitrol) in Colorado. Staff Training , Patient Screening , Medication Administration , and Payor Source Development Addiction Research and Treatment Services (ARTS). AIM (Plan). Baseline use of Vivitrol is 0; started screening

Download Presentation

Promoting the Use of Injectable Naltrexone (Vivitrol) in Colorado

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Promoting the use of injectable naltrexone vivitrol in colorado

Promoting the Use of Injectable Naltrexone (Vivitrol) in Colorado

Staff Training, Patient Screening, Medication Administration, and Payor Source Development

Addiction Research and Treatment Services (ARTS)


Aim plan

AIM (Plan)

Baseline use of Vivitrol is 0; started screening

& dosing in February 2009

4 targets to enhance adoption & utilization:

  • Train and motivate staff Methadonedispensingnurses able

    to do injections rather than just physicians

  • Promote better screening of potential patients by

    counselors

  • Reduce no-shows for injection appointments

  • Increase the number of payor sources


Change do

Change (Do)

  • Schedule and reinforce multiple trainings:

    injection procedure (separate nurse training), effectiveness of this new pharmacological treatment, patient selection

  • Devise new Assessment and Screening form

    to better target potential patients, track counselor behavior for incentives, and reinforce staff training

  • Institute reminder calls for injection appts.

    tested at primary siteto increase show rate and compliance, thus improving outcomes

  • Work with Medicaid and others

    to increase payor sources and build sustainability beyond life of donated supply


Results study

RESULTS (study)

Reminder

Calls

Overall

Utilization

Patients on naltrexone (Vivitrol)


Next steps act

NEXT STEPS (Act)

  • No additional training needed at this time. Staff are on board.

  • Screenings are increasing: Continue to encourage more widespread screening at our 6 clinics

  • Reminder calls worked: continue, expand to other sites

  • Payor sources are still limited: we have been successful with donations, sample program and Signal “mini-grant”, but need to move beyond this for sustainability. Medicaid billing is in the works (need new provider number, correct taxonomy code and separate NPI).Plan to work with child welfare agencies and probation offices.


Impact business case lessons learned

IMPACT (Business Case, Lessons Learned)

  • Potential problem with physician slots

    Program Medical Director requires 1 hour history & physical visit with each client → Physician time is expensive and is prioritized for methadone/buprenorphine intakes. Program cannot afford to purchase additional physician time.

  • Payor source development needs to address cost of physician time.

  • Much better utilization and compliance with injectable form vs. oral form (historical data)

  • ARTS model of methadone dispensing nurses providing the injections at our 3 OTP sites is working quite well

    Addiction Research and Treatment Services (ARTS)


  • Login